INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Similar documents
PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Prostatic ductal adenocarcinoma is a subtype of

Diagnosis, pathology and prognosis including variant pathology

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma

They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

Ductal adenocarcinoma of the prostate: A clinicopathological study

5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy

Intraductal Carcinoma of the Prostate

OMPRN Pathology Matters Meeting 2017

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Update on Reporting Prostate Cancer Pathology

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Prostate Case Scenario 1

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity

Immunohistochemistry in prostate pathology: Recent Advances

Although current American Cancer Society guidelines

Uropathology January Jon Oxley

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Grading Prostate Cancer: Recent Changes and Refinements

Features and Prognostic Significance of Intraductal Carcinoma of the Prostate

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Basement membrane in lobule.

Macro- and microacinar proliferations of the prostate

Flat Epithelial Atypia

Supplemental Information

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Papillary Lesions of the breast

A re-audit of Prostate biopsies from January to December 2010 and 2013.

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Some prostatic diseases

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Prostate Overview Quiz

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

Review Article Recent advances in prostate cancer pathology: Gleason grading and beyond

Int J Clin Exp Pathol 2014;7(2): /ISSN: /IJCEP

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

FINALIZED SEER SINQ QUESTIONS

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Select problems in cystic pancreatic lesions

ADENOCARCINOMA OF THE PROSTATE

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center

High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Inverted (hobnail) high grade prostatic intraepithelial neoplasia and invasive inverted pattern

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

Papillary Lesions of the Breast: WHO Update

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

MEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of

Breast pathology. 2nd Department of Pathology Semmelweis University

Recommendations for the Reporting of Prostate Carcinoma

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case 4 Diagnosis 2/21/2011 TGB

JMSCR Vol 04 Issue 12 Page December 2016

The Role of the Pathologist Active Surveillance for Prostate Cancer

Collaborative Staging

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018

Newer Aspects of Prostate Cancer Underwriting

BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY

A schematic of the rectal probe in contact with the prostate is show in this diagram.

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Metastatic Ductal Adenocarcinoma of the Prostate Cytologic Features and Clinical Findings

Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy

USE OF IMMUNOHISTOCHEMISTRY AS AN ADJUNCT IN THE DIAGNOSIS OF LIMITED ADENOCARCINOMA OF THE PROSTATE CANCER. Jonathan Epstein

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Transcription:

INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein

Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma

High Prostatic Intraepithelial Neoplasia (HGPIN) Considered to be a precursor to many prostatic adenocarcinomas, especially ones arising in the peripheral zone.

Low Grade PIN (LGPIN)

Low Grade PIN Do not comment on in diagnosis Lack of reproducibility in diagnosis Lack of prognostic significance Patients subjected to unnecessary procedures and concern

Incidence of High Grade PIN (HGPIN) on Biopsy Mean 7.6% Median 5.2%

Variations in Incidence of HGPIN on Biopsy Fixative Sampling Patient population? Interobserver threshold

HGPIN on Biopsy: Subsequent Risk of Cancer (35 Studies) Mean 31.5 Mean >50 patients 25.3 Median 24.1 Following Needle of a Benign Diagnosis (21 studies) Risk for Cancer (Mean & Median): 19%

Pathological Factors Most studies have shown if 1 core of HGPIN is present, it does not help predict which men are at higher risk of having cancer following a needle biopsy diagnosis of HGPIN. Risk of cancer following >2 cores with HGPIN is 30%-40%. Reasonable to recommend repeat biopsy.

Clinical Factors to Predict Cancer Of 16 studies, 13 found that serum PSA levels were not predictive of cancer on re-biopsy. Digital rectal exam or transrectal ultrasound not influential in predicting which men with HGPIN on needle biopsy will have carcinoma on re-biopsy.

Repeat Biopsy Recommendation Men do not need a routine repeat needle biopsy within the first year following the diagnosis of HGPIN on 1 core If multifocal HGPIN on biopsy, repeat biopsy 3-6 months. Reasonable to repeat biopsy at 2 or 3 years after limited HGPIN since we don t know the long-term risk of cancer and medicolegal issues if patient not followed-up.

Human Pathology 32: 389-395, 2001

PINATYP High grade PIN with small focus of atypical glands. See note: Note: Adjacent to glands of high grade PIN are a few small atypical glands. While these small glands may represent a small focus of infiltrating cancer, we can not exclude that they represent outpouching or tangential sections off of the adjacent high grade PIN.

PINATYP Follow-up Risk of cancer on repeat biopsy 46% Repeat biopsy recommended

Intraductal Adenocarcinoma of the Prostate (IDC-P)

Cancer 1985; 56: 1566-73 Am J Surg Pathol 1996; 20: 802-4

Of 901 RPs, 141 had IDC with adjacent invasive carcinoma (regular IDC) and 14 (1.5%) showed IDC with cancer distant from IDC (precursor IDC) Regular IDC with cancer had significantly higher Gleason score, more frequent EPE and SVI, more advanced pathological T stage, and lower 5-year BCR than IDC w/o adjacent carcinoma. Prostate cancer with Gleason score >8 in the RP was observed in 73 (52%) cases with regular type IDC-P and in 3 (21%) cases with precursor-like IDC-P.

Multivariate analysis revealed nodal metastasis and the presence of regular type IDC as independent predictors for biochemical recurrence The 5-year biochemical recurrence-free rates were 61% in patients with regular type IDC-P vs. 93% for precursorlike IDC-P.

Precursor-like IDC-P is very uncommonly identified in RPs IDC does not always represent intraductal spread of pre-existing high-grade invasive carcinoma, and at least a subset of IDC could account for a precursor lesion of invasive carcinoma

Intraductal Carcinoma Solid or dense cribriform pattern Loose cribriform or micropapillary pattern with either Marked nuclear atypia: Nuclei 6x normal Comedonecrosis Basal cell layer preserved

PIN vs. IDC-P Atypical glands surrounded by basal cells where the differential diagnosis is between high grade PIN and intraductal carcinoma of the prostate. Repeat biopsy is recommended.

Loss of PTEN (IHC) IDC + infiltrating cancer 38/50 (76%) IDC alone 20/33 (61%) HGPIN 0/19 (0%) Borderline PIN/IDC 11/21 (52%) 7/11 (64%) with loss PTEN subsequent carcinoma on biopsy 5/10 (50%) with intact PTEN subsequent carcinoma on biopsy

IDC-P vs. Infiltrating Carcinoma

When to do IHC for Basal Cells on?idc-p Do basal cell stains when it could make a difference if infiltrating cancer vs. IDC-P only Do basal cell stains if it could possibly make a difference in the grade

Intraductal Carcinoma of the Prostate vs. Intraductal Spread of Urothelial Carcinoma

IDC-P

Intraductal Urothelial Carcinoma

HMWCK

HMWCK

GATA3

Significance of IDC-P only or IDC-P with Low Grade Prostate Cancer on Biopsy

All 6 six RPs with high-grade infiltrating carcinoma with Gleason score 8 or 9 Non-focal EPE in 5/6 RPs 3/16 who did not undergo RP developed bone metastases

Support prior studies that IDC-P represents an advanced stage of tumor progression with intraductal spread of tumor. Consideration should be given to treat patients with IDC-P on biopsy aggressively even in the absence of documented infiltrating cancer.

J Urol 2010; 184: 1328-1333

Follow-up available in 66 cases with only IDC on biopsy Of the 21 RPs available for review findings revealed pathological stage pt3a in 8 (38%), pt3b in 3 (13%), pt2 in 8 (38%). IDC only without identifiable invasive cancer in 2 (10%). Average Gleason score 7.9.

At RP, men in whom prior biopsies showed only IDC typically have high grade (Gleason score >7) invasive adenocarcinoma and most have advanced stage disease (pt3). Definitive therapy is recommended in men with IDC on needle biopsy even in the absence of pathologically documented invasive prostate cancer.

3+3=6 with IDC on Biopsy 51 Total Patients Treated After Diagnosis 4 Chemotherapy (Metastatic at Diagnosis) 14 Radical Prostatectomy 31 Radiation Therapy (+/- ADT) 1 ADT Alone 1 Cryotherapy 13 (+) ADT 18 (-) ADT

Grade and Stage on Reviewed Radical Prostatectomy Specimens (N=14) Gleason Grade Number of Cases 3+3=6 3 (21%) 3+4=7 5 (36%) 4+3=7 4 (29%) 4+4=8 2 (14%) Pathologic Stage Number of Cases pt2 5 (36%) pt3a 5 (36%) pt3b 4 (28%)

Report Intraductal carcinoma is more frequently seen with Gleason patterns 4-5 carcinoma although these are not present on the current tissue samples.

Intraductal Carcinoma Distinctive morphology vs. HGPIN Associated with high grade cancer and poor pathology at RP & relatively poor prognosis with other therapies In most cases it is an advanced stage of tumor progression with intraductal spread of tumor; rarely an in-situ high grade cancer Justified to treat patients with intraductal carcinoma on biopsy even in the absence of documented infiltrating cancer

Grading Intraductal Cancer: Pro Hard to tell if IDC or infiltrating high grade cribriform cancer in many cases w/o doing stains Recommend to treat as if high grade infiltrating cancer so why not just call high grade cancer

Grading Intraductal Cancer: Con In other organ systems (ie. breast) don t grade IDC. Uncommonly, only IDC may be present in the RP so grading biopsy as high grade cancer gives wrong prognostic information. Current recommendation is to do basal cell stains if no obvious infiltrating cancer present and?idc

VOTE IDC should not be graded as Gleason pattern 4 but should be noted typically correlated with aggressive behavior. 82% 1. Yes 2. No 18% 1 2

Prostatic Duct Adenocarcinoma May arise in large periurethral ducts and project into the urethra around verumontanum clinically mimicking UC. Presents with LUTS and hematuria. Rectal often normal. Diagnosis made on TURP

May arise in secondary (peripheral) ducts May present as ordinary (acinar) adenocarcinoma with abnormal DRE or elevated serum PSA levels and diagnosed on needle biopsy.

Relation to Acinar Adenocarcinoma Separate peripheral acinar and central duct Comingling of duct and acinar

Findings at Radical Prostatectomy Large tumor volume Advanced stage Frequent positive margins Higher risk of post-operative failure

Am J Surg Pathol 1999; 23:1471-1479. Ductal Adenocarcinoma of the Prostate Diagnosed on Needle Biopsy Brinker DA, Potter SR, Epstein JI

PIN-Like Ductal Adenocarcinoma

Grading Ductal Adenocarcinoma Usual (cribriform; papillary) Ductal: Gleason pattern 4 With central necrosis: Gleason pattern 5 PIN-like Ductal: Gleason pattern 3

Ductal Adenocarcinoma Growing within Ducts Convention has been to grade and diagnose the same as infiltrating ductal adenocarcinoma as these tumors typically are aggressive and cases of pure intraductal growth of ductal adenocarcinoma have not been reported.

Ductal Terminology Confusing Intraductal carcinoma (ductal refers to location) Acinar morphology (cuboidal cells) growing within ducts and acini Ductal adenocarcinoma (ductal refers to cytology) Ductal morphology (tall pseudostratified columnar cells) typically invasive but also can be growing within ducts and acini

Summary Wide spectrum of intraductal/intraacianr lesions in the prostate Some are precursor lesions and others reflect spread of invasive cancer into ducts/acini. Range from lesions that have very low risk of association with prostate cancer to those associated with increased risk of aggressive prostate cancer Need to differentiate from non-prostatic mimickers